Dr. Daniel Xavier Xibille Friedmann

 Professional experience

• More than 25 years of experience
• Principal investigator of multiple clinical trials, evaluating innovative drugs for the treatment of Rheumatoid Arthritis, Gout, Ankylosing Spondylitis, Psoriatic Arthritis, among others
• Collaboration with the Faculty of Pharmacy of the Autonomous University of the State of Morelos develops a line of research related to the behavior of certain hormones in the inflammatory activity of Rheumatoid Arthritis
• President of the Mexican College of Rheumatology 2016-2018
• Head of Research and Training, Health Services of the State of Morelos, 2016 to date.
• Medical Attached to the Department of Rheumatology, General Hospital of Cuernavaca, 2003-2016

...

 Positions in public associations

• Boss. Department of Research and Training, Health Services of the State of Morelos, since 2016

 Teaching posts

• Dean of the School of Medicine of the Latin American University
• Teacher. Molecular Medicine
• Adjunct Professor of Rheumatology. 2006 - 2018
• He has directed 7 theses. 2007-2018

...

 Education

• Master's degree. Molecular Medicine Autonomous University of the State of Morelos (UAEM). Cuernavaca, Morelos, Mexico. 2014
• Specialty. Rheumatology National Autonomous University of Mexico (UNAM). 2008
• Bachelor's degree. Surgeon. Anahuac University. 1997
• PhD in Pharmacy, Autonomous University of the State of Morelos, 2018

...

 Publications and conferences

• Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis. DOI 10.1007 / s40264-016-0431-z, Megan EB Clowse, Steven R. Feldman, John D. Isaacs, Alexandra B. Kimball, Vibeke Strand, Richard B. Warren, Daniel Xibille, Chen Yan, Donald Frazier, Jamie Geier, James Proulx, Amy Marren, Drug Safety Vol. 9 Pag. 1-1. 2016
• Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyzes of Phase 3 and long-term extension studies. http://dx.doi.org/10.1016/j.reuma.2016.04.010, Sebastião Cezar Radominski, Mario Humberto Cardiel, Gustavo Citera, Annelise Goecke, Juan Jose Jaller, Andrea Barranjard Vannucci Lomonte, Pedro Miranda, Patricia Velez, Daniel Xibillé, Kenneth Kwok, Ricardo Rojo, Erika Gabriela García, Clinical Rheumatology Vol. Pag. 1-1. 2016
• Peripheral blood Leptin and Resistin levels as clinical activity biomarkers in Mexican Rheumatoid Arthritis patients http://dx.doi.org/10.1016/j.reuma.2015.11.011, Carolina Bustos Rivera-Bahena, Daniel-Xavier XibilléFriedmann, Judith González-Christen , Sandra Miriam Carrillo-Vázquez, José Luis Montiel-Hernández, Clinical Rheumatology Vol. 11 Pag. 1-1. 2015
• A Prospective Follow-Up of Adipocytokines in Cohort Patients With Gout: Association With Metabolic Syndrome But Not With Clinical Inflammatory Findings: Strobe-Compliant Article http://dx.doi.org/10.1097/md.0000000000000935, Sergio García-Mendez Carolina Bustos Rivera-Bahena Jose Luis Montiel Hernández Everardo Álvarez Hernández Ingris Peláez-Ballestas Rubén Burgos Vargas Janitzia Vázquez Mellado, Medicine (Baltimore) Vol. 94 Pag. 1-1. 2015
• Leptin and adiponectin as predictors of disease activity in rheumatoid arthritis. DOI: 10.13140 / RG.2.1.2816.1441, Daniel Xibillé-Friedmann Eduardo Ortíz-Panozo Carolina Bustos Rivera-Bahena Marisol Sandoval-Rios, Sara Hernández-Góngora Liliana Domínguez-Hernández Jose Luis Montiel-Hernández, Clinical and Experimental Rheumatology Vol. 33 Pag 471-471. 2015
• Anticardiolpin antibody isotype etermination in amniotic fluid of patients with systemic lupus erythemato his adn / or antiphospholipid syndrome. DOI 10.4236 / OJRA.2014.43024, Xibillé-Friedmann Daniel, Sánchez-Rodríguez Carmen, Cruz-Cruz Polita, García de la Torre Ignacio, Jara-Quezada Luis Javier, Open Journal of Rheumatology and Autoimmune Diseases Vol. 4 Pag. 170-170. 2014
• The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences. DOI: 10.1586 / 1744666X.2014.926219, Mauro Keizerman Catalin Codreanu Rohini Handa Daniel Xibillé-Friedmann Eduardo Mysler Francisco Briceño Servet Akar. 2014
• Update of the Mexican guide for the pharmacological treatment of rheumatoid arthritis at the Mexican College of Rheumatology. DOI: 10.1016 / J.REUMA.2013.10.006, Mario H. Cardiel, Alejandro Díaz-Borjón, Mónica Vázquez del Mercado Espinosa, Jorge Iván Gámez-Nava, Leonor A. Barile Fabris, César Pacheco Tena, Luis H. Silveira Torre, Virginia Pascual Ramos, María Victoria Goycochea Robles, Jorge Enrique Aguilar Arreola, Verónica González Díaz, José Álvarez Nemegyei, Laura del Carmen González-López, Mario Salazar Páramo, Margarita Portela Hernández, Zully Castro Colín, Daniel Xavier Xibillé Friedman, Everardo Álvarez Hernández, Julio Casasola Vargas, Miguel Cortés Hernández, Diana E. Flores-Alvarado, Laura Martínez Martínez, David Vega-Morales, Luis Felipe Flores-Suárez, Gabriel Medrano Ramírez, Antonio Barrera Cruz, Adolfo García González, Susana Marisela López López, Alejandra Rosete Reyes and Rolando Espinosa Morales, Clinical Rheumatology Vol. 10 Pag. 227-227. 2014
• Chronic respiratory dysfunction due to diffuse alveolar hemorrhage in patients with systemic lupus erythematosus and primary vasculitis. http://dx.doi.org/10.1016/j.reuma.2013.01.008, Eva Pérez Aceves, Mario Pérez Cristóbal, Gerardo A. Espinola Reyna, Raul Ariza Andraca, Daniel Xibille Fridmann and Leonor A. Barile Fabris, Clinical Rheumatology Vol. 9 Pag. 263-26. 2013
• Book: Systemic erythematosus lupus. Introduction to Rheumatology INTERSISTEMAS-CMR 260000 PÍNDA. 2012
• A decrease in galectin-1 (GAL-1) Levels correlates with an increase in anti-gal-1 antibodies at the dynovial level in patients with rheymatoid arthritis. http://dx.doi.org/10.3109/03009742.2012.725769, Xibillé-Friedmann D, Bustosrivera-Bahena C, RojasSerrano J, Burgos-Vargas R, Montiel-Hernández JL., Scandinavian Journal of Rheumatology Vol. 42 Pag. 102 -10. 2012
• Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis. http://dx.doi.org/10.1136/ard.2009.111732, Xibillé-Friedmann D, Bustos-Bahena C, Hernández-Góngora S, Burgos-Vargas R, Montiel-Hernández JL, Annals of Rheumatic Disease Vol. 69 Pag. 930-930. 2010
• Guidelines and Recommendations of the Mexican College of Rheumatology for the use of Biological Agents in Rheumatic Patients. http://dx.doi.org/10.1016/s1699-258x(06)73026-1, José Álvarez Nemegyei, Lilia Andrade Ortega, Vicente Baca Ruiz, David D. Bañuelos Ramírez, Ana G. Bernard Medina, Mario H. Cardiel Ríos, Mario A. Chávez López, Luis J. Cruz Alvarez, Rolando Espinosa Morales, Federico Galván Villegas, José L. García Figueroa, Moisés Gutiérrez Ullrich, Roberto Hernández Paz, Jorge Jaimes Hernández, Luis J. Jara Quezada, Ricardo F. López Villanueva, Francisco Medina Rodriguez, Juan E. Olguín Redes, Hugo Peña Rios, Carlos J. Pineda Villaseñor, Manuel Robles San Román, Miguel A. Saavedra Salinas, Luis H. Silveira Torre, Leobardo Terán Estrada, Janitzia Vázquez-Mellado Cervantes, Daniel X. Xibillé Friedmann and Beatriz Zazueta Montiel, Clinical Rheumatology Vol. 2 Pag. 78-78. 2006
• Criteria used for primary care physicians for the diagnosis and referral to the rheumatologist of the patient with rheumatoid arthritis. doi: 10.1016 / S1699-258X (06) 73053-4, Xibillé-Friedmann D, Mondragon-Flores V, de la Rosa CH., Clinical Rheumatology Vol. 2 Pag. 235-235. 2006
• Perception of sexuality in patients with rheumatic diseases: Pilot case and control study. http://dx.doi.org/10.1016/s1699-258x(05)72708-x, D Xibillé-Friedmann, M Álvarez-Fuentes, G FloresFlores, J Gudiño-Quiroz, A Cruz-Valdez, Clinical Rheumatology Vol. 1 Pag. 20-2. 2005

...

 Professional membership

• Physician Assigned to the Health Services of Morelos
• Mexican College of Rheumatology
• American College of Rheumatology

...